<table id="table3" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 3 Average Pharmacokinetic Parameters of Ceftriaxone in Pediatric Patients With Meningitis</caption>
<col align="left" valign="top" width="60%"></col>
<col align="center" valign="top" width="20%"></col>
<col align="center" valign="top" width="20%"></col>
<thead>
<tr>
<th></th>
<th>50 mg/kg IV</th>
<th>75 mg/kg IV</th>
</tr>
</thead>
<tbody>
<tr>
<td>Maximum Plasma Concentrations (µg/mL)</td>
<td>216</td>
<td>275</td>
</tr>
<tr>
<td>Elimination Half-life (hr)</td>
<td>4.6</td>
<td>4.3</td>
</tr>
<tr>
<td>Plasma Clearance (mL/hr/kg)</td>
<td>49</td>
<td>60</td>
</tr>
<tr>
<td>Volume of Distribution (mL/kg)</td>
<td>338</td>
<td>373</td>
</tr>
<tr>
<td>CSF Concentration—inflamed meninges (µg/mL)</td>
<td>5.6</td>
<td>6.4</td>
</tr>
<tr>
<td>Range (µg/mL)</td>
<td>1.3-18.5</td>
<td>1.3-44</td>
</tr>
<tr>
<td>Time after dose (hr)</td>
<td>3.7 (± 1.6)</td>
<td>3.3 (± 1.4)</td>
</tr>
</tbody>
</table>